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ABSTRACT: YIELD OF DIAGNOSTIC TESTS IN THE EVALUATION OF
SYNCOPAL EPISODES IN OLDER PATIENTS
Mallika L. Mendu, Gail McAvay, Rachel Lampert, Jonathan Stoehr, Mary E. Tinetti,
Department of Internal Medicine, Department of Epidemiology and Public Health Yale
University, School of Medicine, New Haven, CT
Syncopal episodes are common among older adults; etiologies range from benign to life-
threatening. We determined the frequency, yield, and costs of tests obtained to evaluate
older persons with syncope. We also calculated the cost per test yield and determined
whether the San Francisco Syncope Rule (SFSR) improved test yield.
Review of 2,106 consecutive patients 65 years and older admitted following a syncopal
episode.
Electrocardiograms (99%), telemetry (95%), cardiac enzymes (95%), and head computed
tomography (CT) (63%) were the most frequently obtained tests. Cardiac enzymes, CTs,
echocardiograms, carotid ultrasounds, and electroencephalography all affected diagnosis or
management in <5% of cases and helped determine etiology of syncope < 2% of the time.
Postural blood pressure, performed in only 38% of episodes, had the highest yield with
respect to affecting diagnosis (18-26%) or management (25-30%) and determining etiology
of the syncopal episode (15-21%). The cost per test affecting diagnosis or management was
highest for electroencephalography ($32,973), CT ($24,881 ), and cardiac enzymes
($22,397) and lowest for postural blood pressure ($17-$20). The yields and costs for
cardiac tests were better among patients meeting, than not meeting, SFSR. For example,
the cost per cardiac enzymes affecting diagnosis or management was $10,331 in those
meeting, versus $111,518 in those not meeting, the SFSR.
Many unnecessary tests are obtained to evaluate syncope. Selecting tests based on history
and examination and prioritizing less expensive and higher yield tests would ensure a more
informed and cost-effective approach to evaluating older patients with syncope.
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1INTRODUCTION
Syncope, defined as the sudden, transient loss of consciousness with spontaneous
recovery, is common, accounting for 3% of emergency department visits and up to 6% of
hospital admissions.1 Older patients present more often with syncope, have higher rates of
hospitalization, and greater morbidity, than younger patients.2 Syncope in older patients
often results from the effects of several coexisting illnesses or medications.3 Evaluation of
older patients following a syncopal episode is challenging because there is a wide spectrum
of possible etiologies, ranging from benign to life-threatening cardiac conditions.
Furthermore, it is important to identify non-life threatening causes of syncope, such as
postural hypotension, that are treatable to prevent the significant morbidity associated with
the condition due to trauma. Because of the varied causes of syncope, clinicians may
pursue a range of diagnostic investigations. Despite thorough evaluations, however, the
etiology of syncope frequently remains undetermined.4,5 Given the prevalence of syncope
among older patients, and the high cost of the extensive diagnostic testing utilized, syncope
evaluation represents a large burden on healthcare costs.
SYNCOPE IN OLDER PATIENTS
Syncope is the seventh most common reason for the emergency admission to acute
hospitals of patients older than age 65 years, and 80% of syncope admissions are for
patients over the age of 65 years.6 Syncope occurs in 23% of patients older than 70 years
during a 10-year period.7 The Framingham Study showed that the yearly incidence of
syncope increased with age, 1.1% per year in patients 70-79 years and 1.7% per year in
patients over 80 years. Certain elements of evaluation are more challenging in this
population compared to younger patients. In general, geriatric patients are prescribed more
medications, have more comorbidities and a worse functional profile than younger
individuals.8 Obtaining an accurate account of the episode may be challenging as recovery
2from syncope may be associated with amnesia in older individuals resulting in inaccurate or
absent history. Distinguishing a syncopal episode from a mechanical fall, also common in
older patients, can be difficult. Older patients are more likely to have atypical presentations
of conditions such as myocardial infarction, pulmonary embolism, and aortic dissection.
Finally, there are data to suggest that older patients have worse outcomes after a syncopal
episode. One study determined that serious events in the 14-days following a syncopal
episode increase with age and that most serious events occur in patients age 60 years and
older.9 Therefore, the issue of when to hospitalize older syncope patients is challenging.
There is often a lower threshold in favor of hospitalization for older than younger patients.
The increased frequency of hospitalization also suggests that older patients undergo more
extensive testing than younger patients following syncopal episodes.
PATHOPHYSIOLOGY
Understanding the pathophysiology of syncope sheds light on the complexity of the
condition in older patients. This complexity likely contributes to the tendency to pursue
extensive diagnostic testing in these patients. Syncope is the result of a sudden and
transient reduction of blood flow to the brain that causes a temporary cessation of cerebral
function. The body's ability to compensate for hypotensive stresses decreases with age.
Age-related physiological changes account for this higher incidence of syncope in the older
and include: changes in heart rate, blood pressure, cerebral blood flow, intravascular
volume regulation, and baroreflex sensitivity.10 In older patients with structural heart disease,
low blood volume in combination with diastolic or systolic dysfunction can lead to a low
cardiac output increasing susceptibility to postural hypotension. Hypertension, found in 30%
of adults 75 years and older, increases the risk of postural hypotension due to reduced
baroreflex sensitivity causing a fall in cerebral blood flow at higher blood pressures. It is a
combination of these physiological changes and age-related disease that threaten blood
pressure homeostasis and increase susceptibility to syncope.3 It is estimated that 25% of
3older syncope patients have age-related postural hypotension. Estimates of the prevalence
of orthostatic hypotension among the older range from 6% in community dwellers to 33% in
hospital inpatients.3
Cerebral blood flow is reduced by 25% in healthy adults over age 60 years due to
decreased cardiac output and vascular stiffening associated with aging.10 Older adults are
also vulnerable due to reduced blood volume secondary to decreased renin and aldosterone
levels, further exacerbated by diuretic treatment. The autonomic nervous system becomes
impaired with age, affecting its ability to control heart rate and vascular resistance. However,
a reduction in the parasympathetic response protects older patients from vagally mediated
reductions in heart rate and blood pressure, which may contribute to lowering the incidence
of vasovagal syncope in older patients.
ETIOLOGIES OF SYNCOPE IN OLDER ADULTS
The unique pathophysiology of syncope in older patients is reflected in the different
frequencies of etiologies in this population compared to younger patients in all age groups
with the condition. The most common etiologies of syncope in all age groups are vasovagal,
postural hypotension, and cardiac arrhythmia. Varied frequencies of these etiologies are
reported among older patients. A recent study of older patients reports the following
frequencies: postural hypotension 20-30%, cardiac arrhythmias up to 20%, vasovagal_up to
15%, multiple etiologies up to 30%, unknown 34-37%.7 Another study compared the
frequencies of etiologies in patients older than 75 years with syncopal episodes to patients
of all age groups and found vasovagal syncope to be most common in the older patient
(36%), though less frequent than in syncope patients of all ages (44%), followed by postural
hypotension (31% compared to 23%), cardiac (16% compared to 15%), drug-induced (5%
compared to 5%), multifactorial (3% compared to 4%), unexplained (9% compared to 10%).9
Although this study did not compare older patients to younger patients (but rather to a
general population that included both younger and older patients), results indicate that
4certain etiologies, such as postural hypotension, are more common with increased age and
others, such as vasovagal, are less common with increased age.
Vasovagal Syncope
The exact mechanism responsible for vasovagal syncope is unknown but is thought
to involve a lack of communication between the autonomic nervous system and
cardiovascular system.11 Healthy older adults are not as prone to vasovagal syncope as
younger patients because of an age-related decline in baroreceptor sensitivity. The
frequency of vasovagal syncope reported in older patients varies from 1-5 % in one study11
to 36%. 9 Despite this wide variability, vasovagal syncope has consistently been shown to be
less common with increasing age. Therefore, though vasovagal syncope is often not
considered a disease in young adults with isolated episodes, such episodes should be
evaluated as a medical condition in older patients.12 Some authors delineate vasovagal
syncope into three forms: cardioinhibitory (involving bradycardia primarily), vasodepressor
(involving hypotension primarily) and a mixed form. Others differentiate between classical
vasovagal syncope, precipitated by emotional or postural stress, and non-classical
vasovagal syncope. Most patients with vasovagal syncope describe a precipitating factor
such as acute stress, prolonged standing, micturition, defecation, and cough. Situational
syncope is consider a subtype of the condition defined by a situational precipitant. A variety
of non-specific symptoms, including fatigue, weakness, diaphoresis, nausea, visual defects,
dizziness, headache, abdominal discomfort, often accompany the episode.
Postural Hypotension
Postural hypotension is defined as a drop in systolic blood pressure > 20 mmHg, or a
drop in diastolic blood pressure >10mmHg from lying to standing positions according to
consensus definitions;13 recordings obtained in the standing position should be taken after
two minutes of standing. A wider range of definitions exist in the literature, with respect to
older patients14,15,16 Prevalence of the condition is reported as 4-33 % in community-living
5older persons and 7-17% in an acute care setting. One study reported that in 2004 there
were approximately 80,094 postural hypotension related hospitalizations, an overall rate of
36 per 100,000, and that hospitalizations increased with age.17 Standing can cause a 40%
reduction in stroke volume and decrease in arterial pressure, which stimulates baroreceptors
in the aortic arch and carotid sinus regulated through the autonomic nervous system.
Therefore, autonomic nervous system dysfunction can underlie postural hypotension in the
form of primary autonomic failure syndromes (pure autonomic failure, multiple system
atrophy, shy dragger, parkinson's disease) or secondary autonomic dysfunction (diabetes
mellitus, multiple sclerosis, spinal cord lesions, chronic renal failure, chronic liver disease).
Autonomic nervous system dysfunction is thought to underlie most cases of postural
hypotension in older patients.7
Cardiac Syncope
Cardiac arrhythmias and structural heart disease result in syncope as a result of
circulatory demands exceeding cardiac output. In older patients arrhythmias are the most
common form of cardiac syncope.9 Sick sinus syndrome is a common form of sinus node
disease associated with syncope, characterized by bradycardia and paroxysmal SVT
leading to syncope in 25-75% of patients.
RECOMMENDED EVALUATION OF SYNCOPE IN OLDER ADULTS
A number of authors over decades describe recommendations for evaluating
syncope.
1 3610-18 Most of these reviews are based on clinical practice and expert opinion.
However, more recent reviews have focused on existing literature and have outlined
recommendations based on both expert consensus and existing data, notably the European
Society of Cardiology guidelines.18
General Recommendations
Several authors recommend that an initial evaluation of syncope include a thorough
history, physical exam (with an emphasis on cardiac and neurological findings), postural
6blood pressure measurements, and electrocardiogram (ECG). The results of this evaluation
should be utilized to help divide patients into two groups, those with certain or suspected
diagnosis and those with unexplained syncope.1,3,6,10 These recommendations are based
primarily on expert opinion. Further evaluation schemes and recommendations have been
developed by various authors. Kapoor WN. 2002 and Brignole M. 2007 recommend, based
primarily on expert opinion, that for those with unexplained syncope and a history of
structural heart disease or abnormal ECG additional testing such as echocardiogram, stress
testing, and loop monitoring should be pursued.
European Society of Cardiology Recommendations
The European Society of Cardiology is the group that has written most extensively
on the diagnostic evaluation and classification of syncope. This group has presented a
number of evaluation recommendations, and these recommendations are currently the only
guidelines with respect to the evaluation of syncope based on both existing literature and
expert consensus.18 The European Society of Cardiology established a Task Force on
Syncope, consisting on experts in the field of syncope, who evaluated the existing literature
in peer-reviewed journals and established classes of recommendations; for example, class I
indications for diagnostic testing are defined as "evidence and/or general agreement that a
given diagnostic procedure/treatment is beneficial, useful and effective." These
recommendations include guidelines with respect to cardiac testing. Specifically, in patients
with suspected heart disease or palpitations associated with syncope, echocardiogram
(ECHO) and prolonged ECG monitoring should be utilized initially; only if these tests are
non-diagnostic should electrophysiology testing be pursued. Telemetry should be utilized
only if patient is at risk of life-threatening arrhythmias or if ECG abnormalities and/or clinical
features suggest arrhythmic syncope (class I indications). If a patient presents with chest
pain related to the episode, in addition to ECHO and ECG monitoring, stress testing should
be utilized as an initial diagnostic step. Loop recording is recommended in patients who
7have unexplained syncope despite a thorough evaluation in patients with clinical or ECG
findings suggestive of an arrhythmic etiology. Indications for holter monitoring include
suspected structural heart disease, abnormal ECG, palpitations, and symptoms suggestive
of arrhythmia or age over 60 years. With respect to vasovagal diagnostic testing, class 1
indications for tilt table testing include patients with recurrent episodes in the absence of
organic heart disease, patients with recurrent episodes in the presence of organic heart
disease if cardiac causes are excluded, and when it is of clinical value to demonstrate
susceptibility to vasovagal syncope. Routine use of basic laboratory tests (measurement of
electrolytes, blood counts, tests of renal function and glucose level) is not recommended
unless indicated by a clinical finding.
Importance of History in Evaluation of Syncope
A thorough, direct history alone has been shown in some studies to result in
diagnosis in approximately 45% of syncope cases.19 Certain etiologies, such as vasovagal
syncope, are more easily diagnosed solely on historical information, compared to other
etiologies such as syncope secondary to cardiac causes. One review suggests that as part
of the history three questions should be considered:19 1.1s the loss of consciousness
attributable to syncope? 2. Is heart disease present? (the presence of heart disease has
been determined to be an independent predictor of a cardiac cause of syncope with
sensitivity of 95% and specificity of 45%, whereas absence of heart disease ruled out
cardiac cause in 97%)20 3. Are there important clinical features that suggest etiology?
Information regarding premonitory period, including symptoms such as light-headedness,
nausea, sweating, weakness and visual disturbances, should be collected.
Evaluation Strategies
A few studies have examined diagnostic patterns to determine effective evaluation
strategies. One study found that in patients with suspected vasovagal syncope diagnostic
yields across all tests, particularly cardiac and neurological testing, were low, and abnormal
8results had no affect on final diagnosis,21 and few patients who had suspected vasovagal on
admission were discharged with a different diagnosis. Another study showed in a
retrospective chart review that neurological tests had a low yield and were over utilized
compared to higher yield testing.22 A few studies have examined the use and utility of
individual testing including brain natriuretic peptide, cardiac enzymes, electrocardiogram,
echocardiogram, telemetry, holter monitoring, loop recording, electrophysiological testing,
head computed tomography, brain magnetic resonance imaging, carotid ultrasound,
electroencephalogram, and tilt table testing.
SPECIFIC DIAGNOSTIC TESTS IN THE EVALUATION OF SYNCOPE
Brain Natriuretic Peptide
Brain natriuretic peptide (BNP), used as a potential measure of underlying heart
disease, has been studied as a test used to evaluate syncope. One study found that a BNP
value of 40 or greater was 82% sensitive and 92% specific for a cardiac cause, which
includes organic cardiac disease, tachycardia, and bradycardia, of syncope.23 Another
study showed that BNP was useful as a predictor of serious outcome for patients with
cardiac syncope;24 a BNP of greater than 100 had a modest sensitivity of 67% for serious
outcome whereas values greater than 1000 had both an excellent positive predictive value
and specificity of 100%.
Cardiac Enzymes
Few studies have examined the value of cardiac enzymes in the evaluation of
syncope. A "rule-out" myocardial infarction (Ml) protocol, involving serial cardiac enzymes, is
often utilized in patients with syncope despite absence of chest pain or coronary artery
disease.25 This is surprising as it is uncommon for older patients with syncope to present
with an Ml. Older studies show that between 6% and 21% of older patients with a
myocardial infarction present with an episode of syncope, and illustrate increasing frequency
of such an incidence with age.
26 Two more recent studies suggest a much lower incidence.
9One study reviewed emergency department patients presenting with syncope and found that
77% underwent a "rule-out" protocol.25 Only one out of 80 patients tested "ruled-in" for Ml,
and the patient had symptoms of unstable angina including chest pain. The authors
subsequently recommended limiting a rule-out protocol to syncopal patients with acute
cardiac symptoms. Similarly, another study conducted a retrospective review of patients
over the age of 65 years admitted with syncope and found that 62% received serial cardiac
enzymes testing.27 Three out of 141 subjects presenting with syncope were diagnosed with
an Ml resulting based on positive cardiac enzymes. Two of these patients reported chest
pain associated with the episode, and the third patient had a history of dementia and was
unable to provide an accurate history. All three patients had non-specific ECG findings. The
authors recommended that only patients with pertinent historical findings consistent with
cardiac ischemia such as chest discomfort or patients from whom an adequate medical
history cannot be elicited should have cardiac enzymes testing.
Electrocardiogram (ECG)
Electrocardiogram is a vital component to the initial evaluation of syncope as it can
help determine the presence or extent of structural heart disease, but as a diagnostic tool it
results in a definitive diagnosis in only 5% of cases.24 It is important to note that except for
older patients often presenting with a multitude of symptoms and signs, acute coronary
syndromes rarely present as syncope as the sole manifestation. Conflicting data exist with
respect to ECG as a predictor of adverse outcomes; one study found that an abnormal ECG
was associated with arrhythmia or death with an odds ratio of 3.2,28 whereas another found
that an abnormal ECG was predictor of arrhythmia with an OR of 8.1.29 The San Francisco
Syncope Rule found an abnormal ECG, along with a history of congestive heart failure,
dypsnea, low Hct, and hypotension, in syncope patients was associated with an increased
risk of short-term adverse events.30 The most alarming ECG signs in a patient with syncope
is alternating complete right bundle branch block with left anterior or posterior fasicular
10
block, suggesting trifasicular conduction system disease and intermittent or impending high-
degree AV block.6 Left and right bundle branch block, on the other hand, are common in
older adults and without accompanying symptoms do not predict syncope.3
Echocardiogram (ECHO)
One author suggests that indications for echocardiogram (ECHO) include abnormal
ECG, exercise induced symptoms, major cardiac risk factors, brief syncope from a seated or
lying position, absence of prodrome, or history of palpitations.17 No study to date has
examined the diagnostic utility of ECHO for the evaluation of syncope.
Telemetry
One study examined the use of telemetry in syncope patients and found that the
mean duration of telemetry use was 4.8 days.31 The studied examined 102 patients
admitted for unexplained syncope, likely cardiogenic syncope (based on a number of criteria
including a history of cardiac disease, clinical presentation suggestive of cardiac disease,
physical examination findings, and electrocardiogram findings) who obtained telemetry
testing. Telemetry detected significant events in 30% of these syncope patients, and
contributed to the diagnosis of cardiac syncope in 18%. Eighty-five percent of this
population had at least one cardiovascular risk factor, and 54% had a prior history of
syncope. Other clinical predictors included age older than 86 years, history of heart failure,
history of atrial fibrillation, and current digoxin use.
Holter Monitoring
Ambulatory holter monitoring is often employed in an outpatient setting and is useful
when history is suggestive of arrhythmic etiology or patients with unexplained syncope at
increased risk of arrhythmias. One study found that 19% of syncope patients had diagnostic
changes on holter over 24 hours; of these patients 21% presented with symptoms typical of
arrhythmia and 79% without such symptoms.32 This study selected all 1,512 patients
referred to an outpatient center for holter monitoring for the condition of syncope over a five
11
year period. Another study showed that by extending monitoring to 48 or 72 hours
arrhythmias a larger percentage of the 826 patients referred to an outpatient center for
holter monitoring for syncope over a five year period. Predictors associated with higher
yields with holter use have been identified and include structural heart disease, depressed
left ventricular function, previous myocardial infarction and age older than 90.
33
Loop Recorder
Continuous-loop event monitoring allows long-term monitoring lasting weeks or
months. An external loop recorder (ELR) is an event monitor that correlates physiological
symptoms with recorded cardiac rhythms. Implantable loop recorders (ILR) are inserted
subcutaneously and have a life of 18-24 months. In a randomized trial of patients with
unexplained syncope in which ILR compared to ELR, ILR was more likely to provide
diagnosis (52% yield in the ILR group vs. 20% yield in the ELR).34 Pooled data from four
recent studies illustrates that diagnosis was found in 34% of ILR patients, of whom 52% had
bradycardia and 11% and tachycardia.
Electrophysiological testing (EP testing)
Diagnostic yield has been shown to be as high as 50% in patients with structural
heart disease (only 10% in those without structural disease) and 34% in those with
abnormal ECG. However, EP studies have low sensitivity for diagnosing bradycardia.35
One study reported that among syncopal patients with heart disease, 21% had inducible
ventricular tachycardia and 34% had bradycardia, whereas in syncopal patients with no
reported heart disease and a normal ecg only 1 % had ventricular tachycardia and 10%
bradycardia.19 A study is diagnostic if the following arrhythmias are identified: sinus
bradycardia, bifasicular block and baseline HV interval of greater than 100 ms, 2nd/3rd degree
His-Purkinje block, high degree His-Purkinje block, induction of sustained monomorphic
ventricular tachycardia, and induction of rapid SVT which reproduces hypotensive or
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spontaneous symptoms. Inducible ventricular tachycardia has a poor prognosis, with 30%
mortality at 3 years, due to risk of cardiac arrest.19
Head Computed Tomography
Little evidence exists in the literature supporting the use of head CT to diagnose
syncope. One author suggest that head CT should be pursued only in patients with a
significant likelihood of seizure, acute focal neurological symptoms, or history of headache
prior to episodes.36 An early study found that head CT was diagnostic in 4% of syncope
patients, all of whom had focal neurological findings or history suggestive of seizure.37 A
more recent study reviewed 649 patients and found that head CT resulted in a diagnosis in
only 2% of cases.22 Another study evaluated 393 patients of whom 39% underwent head
CT, and found that 5 patients met diagnostic criteria of an abnormal result, 38 and
recommended head CT only in patients with neurological findings. Of the patients with
diagnostic results one was found to have focal neurological findings, two had a new
headache, and the remaining two had a history of head trauma.
Brain Magnetic Resonance Imaging (MRI)
An extensive review of the literature revealed no studies that examined the utility of
brain magnetic resonance imaging testing for the evaluation of syncope. Pires et al. 2001
did not support the frequent utilization of the brain MRI, based on evidence of the low yield
of all neurological testing.
Carotid Doppler Ultrasound (Carotid US)
Carotid doppler ultrasound is not indicated in the routine evaluation of syncope
because transient ischemia attacks are rarely accompanied by the loss of consciousness.
However, theoretically fixed neurovascular obstructive lesions may potentiate cerebral
effects of decreasing cardiac output and therefore disrupt blood flow to brain centers
mediating consciousness. One study to date has examined the utility of carotid US in
syncope evaluation.39 The study's main finding was that carotid US identified related CVA
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lesions in 1 .4% of patients. By limiting carotid US to those with new focal neurological
symptoms or carotid bruits on physical exam, testing would have been reduced in half, and
all the patients with diagnostic positive findings would have been identified. Of the 140
patients studied, 78% underwent Carotid US. The test contributed to a diagnosis in 3
patients, 2 of whom had focal neurological features associated with their syncopal episode
(including bilateral carotid bruits on physical exam in one patient). The third patient had a
known intracranial mass but no additional neurological findings. The authors emphasized
that although it is likely that the neurovascular disease contributed to the pathophysiology of
the syncope episodes, it was not necessarily the primary etiology. Predictors of a positive
test were identified and include history of stroke, TIA, carotid disease, coronary artery
disease, focal neurological findings, and carotid bruits on physical exam. The authors
conclude that carotid US may be recommended in patients with such predictors (particularly
focal neurological symptoms and carotid bruits). By utilizing such predictors, 95% of patients
with a positive test and 100% with a diagnostically useful test would have been identified.
Electroencephalogram (EEG)
Electroencephalogram is not recommended for syncopal episodes and provides
diagnostic information in less than 2% of syncope patients.36 A retrospective review of all
EEGs performed over the course of four years for patients presenting with syncope showed
that only 1.46% of patients had epileptiform discharges, and these findings had no impact
on management.40
Tilt Table Testing (TTT)
The use of tilt table testing has been examined primarily in younger patients. No
existing studies have explored the used of TTT in older patients. Also studies have shown
that reliance on history alone may eliminate the need to use TTT to diagnose vasovagal
syncope.
41
PROGNOSIS AND RISK STRATIFICATION
14
Authors have attempted to address concerns about unnecessary hospitalizations
and testing for patients with syncopal episodes by determining patient characteristics that
predict adverse outcomes. Serious or adverse outcomes are defined as death, myocardial
infarction, arrhythmia, pulmonary embolism, stroke, subarachnoid hemorrhage, significant
hemorrhage or anemia requiring transfusion, a procedural intervention to treat a related
cause of syncope or any condition causing or likely to cause a return ED visit, and
hospitalization for a related event.30 By risk stratifying patient clinicians may be able to
better utilize appropriate testing, and some studies have defined decision rules that aim to
predict outcomes for this purpose. The most significant factor in the prognosis and risk
stratification of patients with syncope has been proven to be the presence of heart disease.
In the 1980s studies showed patients with a cardiac cause had a higher 1-year mortality
(18% -33%) than patients with noncardiac causes (0-12%) or patients with an unknown
cause (6%).42 Structural heart disease and abnormal ECG have been identified as two of the
major risk factors for poor outcome. Other factors identified in these studies for the purposes
of risk stratification include age greater than 45, history of heart failure, and history of
ventricular arrhythmias. Based on a review of existing literature in peer-reviewed journals
the European Society of Cardiology includes the following predictors of recurrence: age
greater than 45 years, recurrent syncope at the time of presentation, and greater than four
episodes up to time of admission.
A prospective observational study developed and implemented a clinical decision
rule based on symptoms, ECG findings, past medical history, and physical exam to predict
adverse outcomes or critical interventions.43 The rule identified 66 out of 68 patients with
subsequent critical intervention or adverse outcomes with a sensitivity of 97%, a specificity
of 66%, and a negative predictive value of 99%. If the decision rule had been utilized to
stratify patients, hospital admissions could have been reduced by 48%. This study has yet
15
to be prospectively validated. Other studies have attempted to utilize similar clinical
decision models to predict adverse outcomes.
San Francisco Syncope Rule
A decision rule, titled "The San Francisco Syncope Rule", was developed to identify
predictors of poor outcome at 1 week; patients meet the rule if they have at least one of the
following: abnormal ECG, shortness of breath on presentation, hematocrit less than 30,
history of congestive heart failure, or systolic blood pressure less than 90 mm Hg.31 The rule
had a sensitivity of 96% and specificity of 62% in identifying patients at risk for short-term
outcomes. The San Francisco Syncope Rule was prospectively validated in the same
hospital in a subsequent study and shown to perform with 98% sensitivity and 58%
specificity.44 Other studies have found comparable degrees of sensitivity in subsequent
validation attempts;4546,47 however, one study showed a significantly lower sensitivity of 74%
but comparable specificity of 57%. 48 This study did utilize a patient population that was
unique with respect to demographics (a larger percentage of Black and Hispanic patients
and frequency of syncope admissions was lower) and used a different methodology with
respect to interpretation of electrocardiograms.
IMPLEMENTING DIAGNOSTIC ALGORITHMS
In addition to implementing decision rules such as the San Francisco Syncope Rule,
diagnostic algorithms have been developed by healthcare institutions to improve syncope
testing practices. Diagnostic algorithms often employ established recommendations, such
as the European Society of Cardiology, to determine clinical decision making. Several
studies have examined the utilization of diagnostic algorithms to improve syncope
evaluation methods in an attempt to reduce unnecessary testing and improve the accuracy
of diagnoses. Two studies found that algorithm implementation reduced the frequency of
unknown diagnosis to 14-17.5% of patients.49,50 Another study showed that rates of
diagnosis increased with the implementation of a diagnostic protocol, but there was no
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reduction in costs.51 A study by Brignole et al 2005 utilized the 2004 European Society of
Cardiology diagnostic guidelines and found that a definite diagnosis was established in 98%
of patients.52 In addition, this guideline-based approach to syncope management resulted in
improved overall diagnostic yield and reduced hospital admission. Sarasin et al. 2007
conducted a recent prospective trial to evaluate the implementation of a diagnostic protocol
on testing in syncopal patients.53 After an initial evaluation (consisting of history, physical
exam, ECG, and basic laboratory studies), patients were assigned to a control or
intervention group. The intervention group, standardized based on patient characteristics
such as recurrent syncope, normal ECG and no history of heart disease, underwent testing
such as TTT and CSM; patients with heart disease and abnormal ECG underwent ECHO
and holter; patients with established coronary artery disease underwent stress testing and if
positive underwent coronary angiography; patients with previous Ml, ejection fraction less
than 40% underwent an EP study). A cause of syncope was identified in 39% of patients in
the intervention group vs. 11% in the control group. Although more tests were ordered in
the investigational group (432 versus 362), yield was higher (38% versus 9%).
Some centers have sought to formalize these diagnostic protocols by implementing
syncope management units (SMUs). One study demonstrated savings of 4 million dollars a
year in its institution due to introduction of SMU.54 The SEEDS study (Syncope Evaluation
in the Emergency Department Study) established a syncope unit consisting of continuous
cardiac monitoring for up to 5 hours, hourly postural check, and ECHO in the presence of
abnormal ECG or cardiovascular findings on exam.55 Other testing available included TTT
and EP study. The SMU resulted in a significantly increased diagnostic yield, decreased
hospital admission and reduced hospital stay.
ECONOMIC IMPLICATIONS OF EVALUATING SYNCOPE
Despite the prevalence of syncope and attempts to improve diagnostic yield, little is
known about the costs related to evaluating the condition. One study estimated that
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syncope as a condition results in 2.4 billion dollars in healthcare costs annually and
represents 460,000 hospital admissions in a given year. 56 Another study examined the cost
per hospital admission of syncope patients in 1993 among all United States' hospitals, and
found that mean annual costs ranged from $4929 to $8907, with costs rising in patients with
recurrent admissions.57 The authors attribute the majority of this expenditure to diagnostic
testing costs, but did not pursue analysis of the contribution of individual tests to the overall
cost associated with syncope admissions. The lack of information about the cost associated
with evaluating syncope may be a result of the discrepancy between revenue and cost
incurred by hospitals admitting syncope patients.56 Though the amount charged for
hospitalizations is available, there is an absence of information with respect to costs
incurred by healthcare institutions with syncope admissions. However, despite a lack of
data it is not surprising that estimates of the cost associated with the condition are in the
billions, as syncope is common and often results in extensive utilization of testing.
Though there is a scarcity of data with respect to the cost of evaluating syncope,
there have been studies examining the use of diagnostic testing in clinical practice for all
conditions.58,59 Wennberg et al. have studied the issue of the overuse of inpatient diagnostic
testing in patients with chronic illnesses and have proposed that drastic healthcare cost
savings could be achieved by reducing such practices. These authors advocate for further
research to determine the most cost-effective approaches to evaluation of all conditions and
promote the implementation of data driven evaluation methods in healthcare institutions to
reduce costs. This research may be applied to the condition of syncope, which lacks clear
guidelines with respect to cost-effective diagnostic practices. Studies examining the
diagnostic practices employed in evaluating syncope have suggested that extensive testing
leads to unnecessary expenditure.47,50,52 The implication in these studies is that much of the
testing used to evaluate syncope is unnecessary and that by reducing such practices costs
may be reduced.
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GAPS IN KNOWLEDGE AND OBJECTIVES
A few studies have examined the utility of individual testing in the evaluation of
syncope, however, the contribution of magnetic resonance imaging (MRI), echocardiogram,
telemetry, and other tests to the diagnosis or management of syncope is still unknown.
Specifically the question of how often these tests contribute to diagnosing or managing
syncope remains unanswered. The use of postural blood pressure recordings in the
evaluation of syncope has never been examined in the existing syncope literature.
Several authors have suggested schemes for evaluating syncope, based primarily on
expert consensus rather than empirical evidence,7,60 and attempts to reduce unnecessary
testing by the use of algorithms to improve syncope evaluation methods have been
pursued.51,52,53 However, results from these studies showed improvement in the percentage
of patients in which an etiology was identified but continued use of low yield testing, and
adoption of algorithms did not lead to cost reduction. Identification of specific tests with low
yields with respect to diagnosis or management of syncope has yet to be pursued. The
contribution of diagnostic testing to the costs associated with syncope has not been
determined. Also a calculation of the cost per test that affects diagnosis or management,
which takes into account both yield and cost, has not been pursued to date.
Though attempts have been made to develop decision rules to predict outcomes in
order to risk stratify patients, it is unclear whether the yield and cost-effectiveness of
evaluation can be improved by identifying older adults presenting with syncope in whom test
results are likely to affect diagnosis or management. Patient characteristics such as those
used in The San Francisco Syncope Rule (SFSR) may serve this latter purpose.30
The use of decision rules like the SFSR for the purposes of predicting testing results has not
been pursued to date.
The specific objectives of this study were to:
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• determine the yield of diagnostic testing used in the evaluation of syncope. We
sought to examine how often diagnostic tests were obtained to evaluate older
persons presenting with syncope and whether or not these tests affected diagnosis
or management.
• determine the costs associated with diagnostic tests in the evaluation of syncope. In
addition to calculating the total cost associated with each form of testing, we sought
to calculate the cost per test that affected diagnosis or management, which
incorporates both cost and yield. By undertaking these calculations our aim was to
elucidate low yield, expensive testing.
• explore whether patient characteristics could help guide testing practices. We
utilized the San Francisco Syncope Rule (SFSR) to determine whether such patient
characteristics were associated with the likelihood of cardiac test results affecting
diagnosis or management. Our aim in this analysis was to demonstrate whether the
yield and cost-effectiveness of testing could improve by utilizing such patient
characteristics.
METHODS
Study Design and Population
The study included all patients 65 years and older admitted to an acute care hospital
between July 1, 2002 and December 31, 2006 with an admission or discharge diagnosis of
syncope. Patients were identified based on the presence of an International Classification of
Diseases-Clinical Modification (ICD 9-CM) code of 780.2 as a primary or non-primary
diagnosis in the hospital billing records. Up to 10 diagnoses are listed, enhancing the
likelihood that patients with syncope were identified. Based on review of the medical
records, all patients with presumed loss of consciousness (LOC) were included. Patients in
whom absence of loss of consciousness (e.g. near syncope) was documented were
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excluded. The study was approved by the School of Medicine's Institutional Review Board.
Consent was not obtained from participants because we reviewed existing data; in
accordance with federal guidelines no subject identifiers were included in the data collected.
Records from 2209 admissions in 2009 patients were reviewed. We excluded 103
admissions because of the complete absence of laboratory data, imaging, electronic
medical record, or paper chart. Admissions were included If partial data were available;
there were 2106 admissions included for 1920 patients.
Data Collection
For each admission, emergency department, inpatient admission, and progress
notes; discharge summaries; and laboratory and imaging data were abstracted. We
employed methods recommended to ensure the validity and reliability of data collected,
including a standardized abstraction form, precisely defined variables and criteria, and a
pilot study of 60 charts to refine criteria.61
Data collected included patient age and gender; dates of admission and discharge;
whether presumed loss of consciousness was documented in the record and whether the
episode was witnessed; symptoms and activity at the time of episode and whether
symptoms predicted a significant test result; health conditions; cardiac and neurological
examination findings; postural blood pressure recordings; and cardiac enzymes. Reported
etiology of the syncopal episodes was ascertained from the discharge summary. If no
etiology was reported in the discharge summary, then progress note documentation was
used. Results of electrocardiogram, echocardiogram, head commuted tomography, carotid
ultrasound, stress testing, head magnetic resonance imaging, and electroencephalography
were abstracted from the test reports and progress notes.
A second reviewer blindly abstracted a random sample of 40 admissions. To
measure interrater agreement, we used the prevalence-adjusted, bias-adjusted kappa
statistic.6263 The mean PABAK statistic was 87% (+20%) for the diagnostic test variables.
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Criteria for Defining Results of Diagnostic Tests
An abnormal finding for imaging was defined as any abnormality, no matter how
minor, not seen on prior testing as written in the test reports (for example, mild mitral
regurgitation on echocardiogram and mild slowing on electroencephalography). If no
mention was made of prior testing, the result was assumed to be new. Abnormal cardiac
enzyme results were defined as any troponin-l level > 0.05 (the hospital's reference value).
For postural blood pressure, recordings were documented based on position (supine to
sitting, supine to standing, or supine to sitting to standing) and location obtained (emergency
department and inpatient medicine floors). Postural blood pressure was defined using two
sets of criteria, "strict" and "loose". The strict criteria for postural hypotension was a drop in
systolic blood pressure £ 20 mmHg, or a drop in diastolic blood pressure >10mmHg from
lying to standing positions.13 The loose criteria for postural hypotension was > 10 mmHg
drop in systolic or diastolic pressure or a systolic pressure drop to < 90mm Hg from lying to
sitting or standing positions. This definition incorporated the variability in methods used to
assess blood pressure changes and the wide range of definitions used in the literature,
particularly for older patients.14,15,16
A test result was considered to have affected diagnosis or management if it was
noted in any of test reports, progress notes, or discharge summaries that the test
contributed to, confirmed or established any diagnosis or management decisions. This
definition included documentation of negative and positive test results and all diagnoses,
including those not related to syncope. We also recorded whether it was documented any
where in the medical record that a test result helped determine the etiology of the syncopal
episode. Examples of a test affecting diagnosis included an electrocardiogram identifying
atrial fibrillation and postural blood pressure recordings identifying postural hypotension.
Examples of a test affecting management included an electrocardiogram resulting in the
management of atrial fibrillation with anti-coagulation and beta-blockers and postural blood
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pressure recordings resulting in the management of postural hypotension with hydration.
The criteria detailed above for test results were defined independently such that a test result
could be abnormal but not considered to have affected diagnosis or management or vice
versa.
Patients were considered to have met the SFSR criteria if they had history of
congestive heart failure, hematocrit <30%, abnormal electrocardiogram, shortness of breath,
or systolic blood pressure < 90mmHg at presentation.30
Recurrent Admissions
163 patients out of 1920 total patients had more than one admission during the
four and a half year study period, representing 349 admissions. The percentage of
admissions in which a given test was obtained was calculated as the number of
admissions in which test was ordered divided by total number of recurrent admissions
(349). The percentage of patients in whom a given test was obtained was calculated as
the number of patients in whom test was ordered divided by total number of patients with
recurrent admissions (163). Percentage of repeated testing for a given test was
calculated as number of patients in whom the test was ordered in more than one
admission divided by number of patients in whom test is ordered.
Cost Calculations
Standard billing charges for this hospital were used to calculate the charge per test.
For imaging and electrocardiography, this included professional fees associated with
interpretation. Similar to other studies, we used billing charges for testing and converted
charges to costs by multiplying charges by the hospital's cost to charge ratio,64 because the
hospital does not calculate costs based on individual testing but rather by patient admission.
In order to determine the cost incurred by the hospital a cost to charge ratio of 0.34,
determined by dividing the cost incurred to the hospital for an admission divided by the
amount charged to an admitted patient, was used based on this acute care hospital's cost to
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charge ratio from the State of Connecticut's Annual Report on the Financial Status of
Connecticut's Acute Care Hospitals for Fiscal Year 2007. This ratio was similar to the cost
to charge ratio for syncope patients admitted during the study period of 0.35, determined by
dividing the cost incurred to the hospital for a syncope admission divided by the amount
charged to a syncope admission patient. The cost for telemetry was estimated as the
difference in cost between a monitored and unmonitored bed. For postural blood pressure,
we estimated $5 per test, assuming that it required five minutes at a nurse's wage of $60
per hour, the highest nursing salary on a medicine service. Nurses most often obtain
postural blood pressure recordings at this hospital. We defined the cost per test affecting
diagnosis or management as the cost per test multiplied by the number of tests obtained
divided by the number of test results that affected diagnosis or management.
Statistical Analysis
Statistical analysis was performed using SAS (version 9.1). Yields were reported as
percentages. Denominators were the number of tests obtained and the numerators were the
number of tests in which findings were abnormal, affected diagnosis, affected management,
or helped determine the etiology of the syncopal episode. We stratified patients into those
meeting or not meeting SFSR criteria to compare testing results and cost per test affecting
diagnosis or management. The Fisher exact test was used to compare test results in
patients meeting and patients not meeting the SFSR. A two-sided P value < 0.05 was used
to indicate statistical significance.
RESULTS
Patient Characteristics
Characteristics of the 1920 patients are presented in Table 1. The mean age was 79
(+7.9) years; 53% were female. One hundred and sixty-three patients (8.5%) had two or
more admissions for syncope during the four and a half year period, resulting in 2106
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admissions. The most common preexisting health conditions included hypertension (66%),
hyperlipidemia (32%) and coronary artery disease (32%). The most commonly reported
etiologies were vasovagal and orthostatic hypotension. For 47% of episodes, the etiology
was reported as unknown or not reported in the records.
Diagnostic Testing Obtained in Syncope Evaluation
The frequencies of tests obtained, abnormal findings, and yields are shown in Table
2. The most frequently obtained tests were electrocardiogram (99% of admissions),
telemetry (95%), and cardiac enzymes (95%). Only 5% of admissions had abnormal
enzymes defined as any elevation in troponin-l. Echocardiogram (63%) had the highest
frequency of abnormal findings; most of these were minor structural changes such as mild
mitral regurgitation. Only 2% of echocardiograms revealed new findings, most often aortic
stenosis, that were reported to have contributed to the syncopal episode. Similarly, for
electrocardiogram and telemetry most findings were minor such as premature ventricular
contractions. Telemetry results helped determine the etiology, such as atrial fibrillation or
bradycardia, for 5% of syncopal episodes.
Postural blood pressure was performed in 38% of patients; only 24% of patients had
recordings obtained in the recommended manner, namely lying to standing. Postural blood
pressure had the highest yield with respect to affecting diagnosis (18% using strict criteria)
and management (25% using strict criteria), and was the test most frequently reported to
have helped determine the etiology of the syncopal episode. The tests with the lowest
likelihood of affecting diagnosis or management or determining the etiology of the syncopal
episode were head CT, carotid ultrasound, EEG, and cardiac enzymes.
Head CT affected diagnosis or management in only 28 of 1327 (2%) admissions in
which a CT scan was obtained; 25 of these involved clinically suspected neurologic disease
such as brain metastases, new neurological symptoms, or recent head trauma. Therefore,
the CT scan revealed an unsuspected finding only 0.03% of the time (4/1327). Similarly, 17
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of the 20 cases in which MRI result affected diagnosis or management were suspected
based on history or examination; the MRI scan revealed an unsuspected finding only 1.9%
of the time (3 of 154).
Cost of Diagnostic Testing in the Evaluation of Syncope
The costs per test affecting diagnosis or management are shown in Table 3. This
cost was highest for EEG ($32,973), head CT ($24,881), and cardiac enzymes ($22,397)
and lowest for postural blood pressure ($17-$20). Examples of the cost per test that helped
determine the etiology of syncope include $99,525 for head CT, $77,144 for cardiac
enzymes, $65,946 for EEG and ($23- $33) for postural blood pressure.
Role of the San Francisco Syncope Rule in Cardiac Testing
As shown in Table 4, with the exception of cardiac stress testing, cardiac test results
were much more likely to have affected diagnosis or management or helped determine the
etiology of the syncopal episode in patients meeting the SFSR than in patients not meeting
criteria. The costs per cardiac test affecting diagnosis or management also were much
higher among patients not meeting the SFSR than patients meeting the SFSR. For example
for cardiac enzymes, the cost per test affecting diagnosis or management was $10,331 in
those meeting, versus $1 1 1 ,51 8 in those not meeting, the SFSR.
Recurrent Admissions
As shown in Table 5 most of the patients who presented with recurrent admissions
had 2 admissions (143 of 163). The frequency of testing obtained in recurrent admissions
and recurrence of testing is shown in Table 6. The most frequently repeated tests were
electrocardiogram (98% of patients had the test on a subsequent admission), cardiac
enzymes (94%), and telemetry (89%). The most infrequently repeated tests were
neurological testing: carotid ultrasound (6%), electroencephalogram (3%), and MRI (0%);
however, 47% of patients who obtained a head CT had the test repeated on a subsequent
admission. The percentages of testing that affected diagnosis or management were
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unchanged for specific tests in the subset of recurrent admissions compared to overall
admissions as detailed in Table 2.
DISCUSSION
Yield of Testing
In this study, we found that cardiac and neurologic tests were commonly obtained in
the evaluation of syncope in older patients despite minimal effect on diagnosis or
management. Other than MRI scans, neurological test results affected diagnosis or
management in fewer than 2% of cases. In the few cases in which neurological tests were
helpful, neurological conditions were suspected based on history or examination. Cardiac
testing, particularly cardiac enzymes obtained in over 95% of admissions (and 94% of
repeated admissions), also had low yields overall. Conversely, postural blood pressure
recordings had the highest yield, but were performed in only about a third of admissions;
recordings were frequently performed inadequately particularly in the emergency
department. This disparity between performance and yield was even more pronounced
when contribution to determining etiology of syncopal episodes was compared. Postural
blood pressure helped determine the etiology of syncope in 16-21% of cases compared to
cardiac enzymes in less than 1% of cases.
Recurrent Testing
Nine percent of patients in this study had recurrent admissions for syncope.
Repeated testing was common with electrocardiogram, telemetry, cardiac enzymes, and
head CT. Recurrent admissions with repeated testing contribute further to the low yield of
testing illustrated in this study.
Etiologies of Syncopal Episodes
As in previous studies, vasovagal episodes and orthostatic hypotension were the
most frequently reported etiologies. Because these etiologies are based on medical record
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reports, it is not possible to verify the accuracy of the stated etiologies. The lack of an
etiology in almost half of patients despite extensive testing was also similar to prior reports
of older adults.1,3 The fact that no etiology was reported in almost 50% of episodes, despite
the multiple tests, attests to the complex nature of syncope. Though there was no difference
in the average number of tests ordered between patients who had an established etiology of
syncope and those who did not, neurologic testing was more heavily utilized in patients
without an established etiology compared to those with an established etiology. As
suggested by other authors, this high percentage of undiagnosed cases may be a symptom
of the random use of low yield testing.22Algorithm-based evaluations, which we did not
examine in this study, by design have resulted in higher percentages of patients with a
diagnosed etiology.52,53,54
Cost of Evaluating Syncope
The lowest likelihood of useful test results and, therefore, the highest costs per yield
were incurred by EEG, head CT, and cardiac enzymes. Although only troponin-l was used
to define abnormal results,65 the total cost per set of cardiac enzymes included creatine
kinase and creatine kinase MB. If troponin-l alone was obtained the cost per cardiac
enzymes affecting diagnosis and management would decrease from $22,397 to $4813.
Postural blood pressure measurements represented the lowest cost per test affecting
diagnosis and management at $17. This figure maybe lower or higher in actual practice
based on who is performing the blood pressure measurements (our assumption utilized five
minutes of the highest nursing salary on a general medicine floor) but the magnitude is likely
accurate for comparison to other testing costs.
San Francisco Syncope Rule to Guide Cardiac Testing
Application of the San Francisco Syncope Rule markedly improved yields and
lowered costs without compromising identification of persons with life threatening cardiac
conditions. The finding was most notable for cardiac enzymes. Cardiac enzymes affected
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diagnosis or management in only four of 1255 (0.3%) patients not meeting SFSR criteria.
Significant differences in yields were also seen for echocardiogram and telemetry between
those meeting and not meeting SFSR criteria.
Comparison of Findings to Prior Studies
While ours was the first study to evaluate cost from the perspective of effect on
diagnosis and management, the low yields for most of the tests were consistent with prior
studies. Grossman et al. and Link et al. also found that serial cardiac enzymes had little
impact on diagnosis in syncope.25,27 Head CT,38 carotid US,39 and EEG40 are all known to
rarely identify lesions contributing to syncope. The diagnostic value of postural blood
pressure recordings supports guideline recommendations that the initial evaluation of
syncope should entail history, physical examination, electrocardiogram and postural blood
pressure measurements.2,7,8, 56
Study Strengths
Strengths of our study include a large sample size, standardized medical abstraction,
consistent definitions and criteria, and blinded re-abstraction to ensure reliability. In defining
criteria for tests affecting diagnosis and management, we reported results that contributed to
any diagnosis or management decision in any way. For imaging studies, we included any
abnormally, no matter how minor, not seen on prior testing. We used broad and inclusive
criteria to define a test's utility so that we would not underestimate the yield of any
diagnostic test. If we had utilized definitions that were too limited, our assertion that certain
tests have limited diagnostic yield this would be less reliable.
Study Limitations
There are limitations to our study. First, we report the retrospective experience of a
single hospital - although comparison to previous studies suggests that this experience is
representative of other hospitals.
23334'41'42'43 Also because we used the ICD 9-CM code of
780.2 to identify syncope admissions it is possible that we may have missed some patients
29
with syncope without this ICD 9-CM code. These patients were likely either admitted
primarily for other conditions and may have developed syncope during the course of the
admission or were admitted with an established etiology; in either situation an extensive
workup for syncope was likely not pursued in these patients since they were not given an
ICD 9-CM code of syncope and their exclusion should not introduce any bias into the study.
Also as we included patients with an admission or discharge, primary or non-primary
diagnosis the number of missed patients is likely small and should not affect our results.
Second, all clinical decisions may not have been documented in the medical record. For
example, we likely underestimated the contribution of negative results to diagnosis or
management. Only 3% of test results that were reported to have affected diagnosis or
management were negative results; no negative test results were noted to have helped
determine the etiology of the syncopal episode. Third, because we did not evaluate tests
performed after the hospitalization, we could not comment on outpatient-based tests such
as loop recorders and tilt table testing. Records of electrophysiological studies performed
during hospitalizations were not available and were not included in the study. We also did
not evaluate the yield of commonly performed laboratory testing such as hematocrit and
glucose. Finally, our calculation of costs using a cost to charge ratio (as defined in the
methods section) is an estimation based on charges, which is an approach to cost
calculation used by other studies in the absence of hospital estimates of cost.5662 The
hospital's cost to charge ratio utilized in the calculation was nearly identical to the cost to
charge ratio of patients admitted with syncope, which supports the accuracy of our
estimation. Our calculation of costs may have underestimated total costs because it does
not include all tests and procedures performed nor the cost of hospitalizations, estimated to
be between $7460 and $9950 per admission.
Implications
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Because syncope is a common reason for hospital admission, the evaluation of this
condition is currently an important source of revenue for hospitals. Extrapolating our results
nationally, assuming approximately 460,000 hospitalizations per year for syncope,56 yearly
costs associated with the most commonly obtained tests may be nearly 6 billion dollars. The
issue of revenue compared to cost incurred is significant as there is an absence of data with
respect to the costs incurred by healthcare institutions associated with evaluating syncope
patients. Further delineation of cost versus revenue would shed light on effective means to
reduce healthcare budgets. The main sources of cost associated with the evaluation of
syncope are the cost of hospitalization and the cost of diagnostic testing; approaches to
reduce either sources of cost would help alleviate the burden on healthcare budgets.
Studies have examined efforts to reduce the cost of hospitalization, by reducing the duration
of hospitalization for syncope patients, enforcing strict guidelines on patients admitted for
the condition, and by creating syncope management units.30,53,56 Our study has examined
the issue of the cost associated with testing, and reducing such costs is an approach yet to
be adopted in order to reduce the overall cost of evaluating syncope.
The low yield of most tests means that a significant number of unnecessary tests are
obtained in evaluating syncope. This unnecessary testing contributes to substantial
healthcare cost. Studies have demonstrated that unnecessary testing is a significant
contributor to rising healthcare costs; such testing has been proposed as a target for cost
savings.58,59 Research exploring chronic illnesses in the Medicare population has illustrated
that the availability of resources often leads to the overutilization of such resources and to
an increase in expenditure. Syncope is similar to such chronic conditions which affect
predominantly older patients and often involve varied diagnostic testing. In the case of
patients hospitalized for syncope, both local clinical practice and availability of testing likely
contribute to the overutilization of resources in evaluating the condition. Given the easy
availability of neurologic and cardiac testing it is not surprising that these tests are often
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employed in evaluating syncope and that a large percent of these tests do not contribute to
diagnosing the condition. However, our results suggest that clinicians should be more
selective when ordering tests to evaluate syncope and that such an approach has the
potential to drastically lower costs.
Our study results suggests how clinicians might be more selective when obtaining
tests to evaluate syncope, by avoiding low yield testing that has been elucidated in this
study. One goal of the evaluation of syncope is to detect conditions, particularly life-
threatening ones such as arrhythmias, which may be present in patients with syncope.
Though our data suggests that cardiac testing, particularly cardiac enzymes, is often low
yield, we also recognize that there are certain patients for whom such testing is applicable
and useful. For this reason we sought to utilize patient characteristics such as the SFSR
criteria to identify such patients. In this study we found the SFSR criteria to be helpful in
identifying patients very unlikely to benefit from cardiac testing. Using the SFSR criteria
markedly improved the yield of cardiac tests in comparison to the general study sample.
There have been conflicting studies regarding the validation of the SFSR;44,48 other criteria,
yet to be validated, have been used to predict adverse outcomes43 and may be helpful as
well in serving as predictors of diagnostic yield. Our results suggest that using patient
characteristics such as the SFSR may help determine in whom certain tests, particularly
cardiac enzymes, and perhaps telemetry, are indicated, resulting in a marked savings costs
without adversely affecting the identification or management of patients with life-threatening
etiologies. This finding indicates a need for further research regarding predictive and
feasible criteria that can be utilized as screening tools for testing. Such tools would improve
the utilization of appropriate testing and could also reduce costs.
Because almost one quarter of older patients who experience a syncopal episode
suffer serious injuries such as a hip fracture during the episode,66 another goal is to identify
non-life threatening, but treatable, etiologies such as postural hypotension. Our study
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suggests that this inexpensive test is greatly underutilized, resulting in many missed
opportunities to institute effective treatment strategies such as medication reduction. The
underutilization of postural blood pressure recordings observed in this study may be due to
a number of factors. First, local clinical practice often dictates the utilization of testing in
conditions such as syncope; clinicians at this institution may have been more likely to order
cardiac enzymes as opposed to postural blood pressure recordings due to customary
practice. Second, ease of obtaining postural blood pressure recordings must be considered.
Often recordings must be obtained by the clinicians themselves, which requires more time
than ordering laboratory or imaging testing. Finally, despite the consensus guidelines
defining postural hypotension, there is no clear standard definition for older patients with
postural hypotension. A range of definitions exist among older patients and studies have
examined the reliability of postural blood pressure recordings,67 indicating a need to further
develop criteria for postural blood pressure and improve reliability of measurements.
Studies such as this that illustrate the utility and cost effectiveness of postural blood
pressure recordings may promote the utilization of this test.
Finally, our findings convincingly show that neurological imaging is not warranted in
the evaluation of syncope unless there is a suspected neurological disease or event. Low
yield neurologic testing has been illustrated in prior studies and this finding further supports
the use of history and physical examination findings to direct testing. Our results reveal that
neurologic testing could be drastically reduced and by eliminating unwarranted neuralgic
testing associated costs would be significantly reduced.
Availability of national guidelines may help lessen the roles of local custom and
uncertainty in the ordering of unnecessary tests. The fact that syncope is a condition with a
multitude of etiologies that come under the purview of several medical specialties may have
hindered the development of comparable guidelines in this country. Despite this challenge,
relevant specialists such as cardiologists, geriatricians, neurologists and general internists
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should consider jointly addressing the challenge of evaluating syncope and promote an
evidence-based approach to diagnosis. Instituting evidence-based diagnostic guidelines,
such as have been developed by the European Union,18 might lessen the extent of
unnecessary testing.
In summary, basing subsequent testing on the results of the initial history and
examination and prioritizing higher yield tests would ensure a more informed and cost-
effective approach to evaluating older patients with syncope.
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Table 1. Characteristics of study patients (N=1920 )
n (%)
Age - years (mean ± SD) 79.3 ±7.9
Female 1,022(53)
Length of stay - days (mean ± SD) 3.5 ±4.0
Previous admission for syncope* 163(9)
Hypertension 1,265(66)
Hyperlipidemia 666 (32)
Coronary artery disease 607 (32)
Diabetes 396(21)
Atrial fibrillation 348(18)
History of stroke 301 (16)
Dementia 251 (13)
Previous myocardial infarction 171 (9)
Atrial ventricular block 103(5)
Sick sinus syndrome 67(4)
Symptoms preceding syncopal episode
Lightheadedness 492 (26)
Chest pain 82(4)
Mental status change 81 (4)
Symptoms suggestive of stroke" 24(1)
Seizure 9 (0.5)
Physical examination findings
Abnormalities on cardiovascular examination** 656 (34)
Neurological deficits on examination5 112(6)
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Table 1. Characteristics of study patients (N=1920*) (continued)
Reported etiologies of syncopal episode11
No etiology listed or unknown11 980 (47)
Vasovagal 453 (22)
Orthostatic Hypotension 282(13)
Arrhythmia 253 (12)
Dehydration 178(8)
Other cardiac causes11 85 (4)
Situational11 68 (3)
More than one etiology listed 199(9)
*1920 patients with 2106 admissions
* Previous admission for syncope includes admissions during four and half year
study period
*Abnormalities on cardiovascular examination included any of abnormal rate,
abnormal rhythm, murmurs, S3, S4.
§ Neurological deficits on examination included any of sensory, motor, cranial
nerve, or mental status deficits.
" Symptoms suggestive of stroke included acute neurological symptoms or signs
such as motor deficits, dysarthria, excluding acute mental status changes.
11 Reported etiology of syncopal episode was ascertained primarily from discharge
summary. If no etiology was reported in the discharge summary, then progress
note documentation of an etiology was used. Sum of percentages, calculated
using a denominator of total number of episodes (2106), does not equal 100%
because more than one etiology may have been listed for a patient. No
42
etiology listed or unknown included patients for whom no documentation of
etiology was noted in the discharge summary or progress notes and patients
for whom it was documented that no etiology could be determined. Other
cardiac causes included aortic stenosis, cardiac ischemia etc. Situational
etiology included etiologies such as micturition or defecation related syncope.
Table 2. Diagnostic tests obtained in evaluation of syncopal episodes in older patients (N=2,106)*
Tests Obtained
Electrocardiogram 2081 (99)
Telemetry 2001 (95)
Cardiac enzymes 1991 (95)
Head commuted 1327(63)
tomography
Echocardiogram 821 (39)
Postural blood pressure- 808 (38)
strict criteria5
loose criteria5
Carotid ultrasound 267(13)
Electroencephalogram 174(8)
Head magnetic resonance 154(7)
imaging
Abnormal Affected Helped determine Affected
Findings* Diagnosis* etiology t Management*
n%
438(21) 147 (7) 72(3) 153(7)
314(16) 212(11) 95(5) 245(12)
108(5) 31(2) 9 (0.5) 29(1)
138(10) 28(2) 7 (0.5) 28(2)
516(63) 35(4) 13(2) 36(4)
230 (28) 142(18) 122(15) 202 (25)
445 (55) 212 (26) 173(21) 241 (30)
122(46) 2(1) 2 (0.8) 6(2)
68 (39) 2(1) 1 (0.6) 2(1)
46 (30) 20(13) 3(2) 19(12)
Table 2. Diagnostic tests obtained in evaluation of syncopal episodes in older patients (N=2.106)* (continued)
Cardiac stress test 129(6) 53(41) 13(10) 2(2) 12(9)
* There were 2106 admissions for 1920 patients
* Abnormal Findings were defined as abnormal values for cardiac enzymes and postural blood pressure as outlined in
Methods; for imaging studies, abnormal findings were defined as any abnormalities that were not seen on prior testing as
noted in the test reports.
* Denominators were the number of tests obtained. Affected Diagnosis was defined as any test result that were noted in test
reports, progress notes or discharge summary to have contributed to, confirmed, or established any diagnosis; examples
included an electrocardiogram identifying atrial fibrillation or postural blood pressure measurements meeting criteria for
postural hypotension. Helped determine etiology of syncope was defined as any test results that were noted in test
reports, progress notes or discharge summary to have helped determine etiology of the syncopal episode. Affected
Management was defined as any test results that were noted in test reports, progress notes or discharge summary to have
contributed to any management decision; examples included electrocardiogram resulting in the management of atrial
fibrillation with anti-coagulation and beta-blockers or postural blood pressure recordings resulting in the management of
orthostatic hypotension with hydration.
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The strict criteria for postural blood pressure was a drop in systolic blood pressure > 20 mmHg or a drop in diastolic blood
pressure >10mmHg from lying to standing positions. The loose criteria for postural blood pressure was defined as > 10 mmHg
drop in systolic or diastolic pressure or a systolic pressure drop to < 90mm Hg from lying to sitting or standing positions.
Table 3. Costs of diagnostic tests in the evaluation of syncopal episodes (N=2106)*
Tests obtained Cost per test** Total Cost * Cost per test affecting diagnosis or
management5
Electroencephalogram
Head commuted tomography
Cardiac enzymes
Troponin-l alone
Carotid ultrasound
Head magnetic resonance
imaging
Cardiac stress test
Echocardiogram
Electrocardiogram
Telemetry
Postural blood pressure*
$1,115X.34=$379
$1,545X.34=$525
$357X.34=$121
$78X.34=$26
$1,294X.34=$440
$3,316 X.34=$1 127
$2,492 X.34=$848
$809 X.34=$275
$221 X.34=$75
$255 X.34=$87
$5
$65,946=($379X174)
$696,675=($525X1327)
$694,298=($1 21X5738 sets)
$149,188=($26X5738 sets)
$117,480=($440X267)
$173,558=($1 127X154)
$109,392=($848X129)
$225,775=($275X821)
$156,075=($75X*2081)
$174,087=($87X2001)
$4040=($5X808)
$65,946/2=$32,973
$696,675/28=$24,881
$694,298/31 =$22,397
$149, 188/31 =$481 3
$117,480/6=$1 9,580
$173,558/20=$8678
$1 09,392/1 3=$841 5
$225,775/36=$6272
$1 56,075/1 53=$1 020
$174,087/245=$710
$4040/241 =$17
* There were 2106 admissions in 1920 patients
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**Cost per test was calculated as the charge per test multiplied by the cost to charge ratio of 0.34, based on the 2007 Yale New
Haven Hospital Cost to Charge Ratio from the State of Connecticut's Annual Report on the Financial Status of Connecticut's Acute
Care Hospitals for Fiscal Year 2007
* $5 calculated based on 5 minutes of nurses time at $60 per hour wage. Loose Criteria for postural blood pressure, as defined in
Methods, was used to calculate costs. If strict criteria, as defined in Methods were used, then the cost per test affecting diagnosis
or management was $20.
*The total cost is equal to the number of tests obtained multiplied by the cost per test.
5 Cost per test affecting diagnosis or management was calculated as the total cost divided by the number of tests that affected
diagnosis or management. (Affected Diagnosis was defined as any test result that were noted in test reports, progress notes or
discharge summary to have contributed to, confirmed, or established any diagnosis; examples included an electrocardiogram
identifying atrial fibrillation or postural blood pressure measurements meeting criteria for postural hypotension. Affected
Management was defined as any test results that were noted in test reports, progress notes or discharge summary to have
contributed to any management decision; examples included electrocardiogram resulting in the management of atrial fibrillation
with anti-coagulation and beta-blockers or postural blood pressure recordings resulting in the management of orthostatic
hypotension with hydration.)
Table 4. Association between San Francisco Syncope Rule* and cardiac test results in older patients presenting with
syncope (N=2106V*
Met SFSR (N=807)Test Results
Cardiac Tests
Cardiac enzymes
Obtained
Affected diagnosis or management
Helped determine etiology of syncope
Cost per affect on diagnosis or
Management
Telemetry
Obtained
Affected diagnosis or management
Helped determine etiology of syncope
Cost per affect on diagnosis or
Management
Did not meet SFSR (N=1299)
766 (95)
27/766 (4)
8/766(1)
$10,331
770 (95)
146/770(19)
54/770 (7)
$457
n (%)
1225(94) 0.08
4/1255(0.33) <0.001
1/1255(0.08) 0.003
$111,518
1231 (95) 0.54
99/1231 (8) O.001
41/1231 (3) <0.001
$1,078
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Table 4. Association between San Francisco Syncope Rule* and cardiac test results in older patients presenting with
syncope (N=2106)* (continued)
Echocardiogram
Obtained
Affected diagnosis or management
Helped determine etiology of syncope
Cost per affect on diagnosis or
Management
Cardiac stress test
Obtained
Affected diagnosis or management
Helped determine etiology of syncope
Cost per affect on diagnosis or
management
333(41)
26/333 (8)
9/333 (3)
$1,877
56(7)
7/56(13)
1/56(2)
$6,582
488 (38) 0.10
10/488(2) <0.001
4/488 (0.8) 0.045
$7,151
73(6)
6/73 (8)
1/73(1)
$13,423
0.22
0.56
1.00
* There were 2106 admissions in 1920 patients
* San Francisco Syncope Rule defined as at least one of a history of congestive heart failure, hematocrit <30%, abnormal
electrocardiogram result, shortness of breath, or systolic blood pressure <90mmHg.
Table 5. Recurrent admissions of syncopal episodes in older patients
Number of patients with recurrent admissions during 4.5 year period
Number of patients with 2 admissions
Number of patients with 3 admissions
Number of patients with 4 admissions
Number of recurrent admissions during 4.5 year period
50
163
143
17
3
349
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Table 6. Repeated diagnostic testing obtained in evaluation of syncopal episodes in older patients (163 patients, 349
admissions)
Tests % Admissions Obtained*
N=349
% Patients Obtained**
N=163
n%
%Repeated*
Electrocardiogram 346 (99) 163(100) 160/163(98)
Telemetry 324 (93) 161 (99) 144/161(89)
Cardiac enzymes 338 (97) 162 (99) 153/162(94)
Head commuted tomography 233 (67) 138(85) 65/138(47)
Postural blood pressure 146(42) 105(64) 29/105(28)
Echocardiogram 1 1 1 (32) 90 (55) 16/90(18)
Carotid ultrasound 53(15) 50(31) 3/50 (6)
Electroencephalogram 31 (9) 29(18) 1/29 (3)
Head magnetic resonance imaging 27(8) 26(16) 0/26 (0)
Cardiac stress test 24(7) 21 (13) 3/21 (14)
* % Admissions obtained calculated as the number of admissions in which test was ordered divided by total number of recurrent
admissions (349)
**% Patients obtained calculated as the number of patients in whom test was ordered divided by total number of patients with
recurrent admissions (163)
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* % Repeated testing calculated as number of patients in whom the test was ordered in more than one admission divided by
number of patients in whom test is ordered
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